CytoDyn Invited to Present at XVI World AIDS Conference.SANTA FE, N.M. -- CytoDyn, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CYDY) has been invited to present clinical results from Cytolin(R) at the Treatment Horizons Forum of The AIDS Institute to be held on August 12, 2006 in conjunction with the XVI International AIDS Conference Education, networking and the promotion of best practice are essential to enhancing the response to HIV/AIDS. IAS conferences provide opportunities to share experience, and increase the knowledge and expertise of professionals working in HIV/AIDS. in Toronto. "CytoDyn will show how its targeted immune therapy reduces viral activity while avoiding the emergence of drug-resistant strains of HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. ," according to Allen D. Allen, the Company's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . The need to continually produce new anti-microbial agents to compensate for the emergence of drug resistant strains of HIV will ultimately be limited by resources, infrastructure, and toxicity, Allen believes. Dr. Glenn Morrison, Director of Clinical Development and Regulatory Affairs for Symbion Research International, Inc., CytoDyn's CRO, will present Phase I/II data demonstrating the antiviral effects and absence of liver toxicity in individuals who have failed Highly Active Antiretroviral Therapy Noun 1. highly active antiretroviral therapy - a combination of protease inhibitors taken with reverse transcriptase inhibitors; used in treating AIDS and HIV drug cocktail, HAART (HAART HAART highly active antiretroviral therapy. HAART Highly active antiretroviral therapy, triple combination therapy AIDS The concurrent administration of 2 nucleoside reverse transcriptase inhibitors–eg, AZT and 3TC, and a protease ) after Cytolin(R) was used to protect CD4+ T lymphocytes from the anti-self, anti-CD4 cytotoxic T lymphocytes that proliferate uniquely in humans infected with HIV. CytoDyn has been developing this targeted immune therapy since 1997. The underlying science was first published in the peer-review journals during the early 1990s. "Millions of people around the world are desperate for the successful clinical development of a commercially available immune-based therapy for the emerging crisis of drug-resistant HIV. Cytolin(R) is one of the very few promising candidates in advance stage clinical development that shows clinical promise to address this urgent need globally," said David Miller, Board Member of the AIDS Institute and long time AIDS treatment activist. "An immune therapy that suppresses drug resistant HIV could extend the useful lives of the antiretroviral drugs Antiretroviral Drugs Definition Antiretroviral drugs inhibit the reproduction of retroviruses—viruses composed of RNA rather than DNA. The best known of this group is HIV, human immunodeficiency virus, the causative agent of AIDS. that people with AIDS The People With AIDS (PWA) Self-Empowerment Movement was a movement of those diagnosed with AIDS and grew out of San Francisco. The PWA Self-Empowerment Movement believes that those diagnosed as having AIDS should "take charge of their own life, illness, and care, and to minimize have been depending upon, such as recent additions to the armamentarium ar·ma·men·tar·i·um n. pl. ar·ma·men·tar·i·ums or ar·ma·men·tar·i·a The complete equipment of a physician or medical institution, including drugs, books, supplies, and instruments. by Gilead (Nasdaq: GILD)," Miller added. About HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome HIV, the virus that leads to acquired immune deficiency syndrome Acquired immune deficiency syndrome (AIDS) A viral disease of humans caused by the human immunodeficiency virus (HIV), which attacks and compromises the body's immune system. (AIDS), remains a global epidemic. World health officials estimate 39 million people are now infected with HIV. Some three million people died of AIDS last year, worldwide, and millions more are expected to die from AIDS this year (source www.aegis.com). With the rate of infection accelerating in many parts of the world, the search for an effective immune-based therapy for HIV is one of the highest public health priorities, according to Miller. About CytoDyn CytoDyn, Inc. is a company focused on developing products to treat and to prevent serious human diseases. CytoDyn, Inc. is a Colorado corporation with its home office in Santa Fe, NM. The company's shares are traded on the Over The Counter Bulletin Board under the symbol CYDY. "Cytolin" and "CytoDyn" (as used to identify a particular class of products) are the registered trademarks of CytoDyn, Inc. Our graphic logo is the registered mark of CytoDyn, Inc. For more information, including a review of the literature, please visit our web site at www.cytodyn.com. About The AIDS Institute The AIDS Institute (TAI) is a leading national public policy research, advocacy, and education agency with offices in Tampa, Florida and Washington, DC, and is affiliated with The Division of Infectious Diseases and Tropical Medicine at the University of South Florida's College of Medicine. Visit its web site at www.theaidsinstitute.org. About The XVI World AIDS Conference AIDS 2006 will be a landmark opportunity for science, government, community and leadership from around the world to advance our collective response to the epidemic. AIDS 2006 is rooted firmly in the vision that the International AIDS Conference must foster an environment of scientific inquiry, forthright dialogue, collective action, and greater accountability among all parties. The conference theme for AIDS 2006 is Time to Deliver, reminding us of past and present commitments for action on HIV/AIDS and demanding accountability for those promises at every level of the response. AIDS 2006 will be a landmark opportunity to review our collective experience with the epidemic and set an agenda for future action. For more information visit www.aids2006.org AIDS 2006 - XVI International AIDS Conference - 13-18 August 2006 - Toronto Canada. Disclaimer Forward looking statements are statements that are not historical facts. CytoDyn's management makes forward looking statements concerning the Company's expected future operations, performance and other developments. These forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. There can be no assurance that such risks and uncertainties, or other factors, will not affect the accuracy of such forward-looking statements. It is impossible to identify all factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, government regulation, managing and maintaining growth, victimization victimization Social medicine The abuse of the disenfranchised–eg, those underage, elderly, ♀, mentally retarded, illegal aliens, or other, by coercing them into illegal activities–eg, drug trade, pornography, prostitution. by white-collar offenders, and the effects of adverse publicity, litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. , competition, and other factors that may be identified from time to time in the Company's announcements. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion